The recent instability in global supply have highlighted the value of securing vital medications like Ivermectin. Dependence on overseas producers exposes countries to considerable vulnerabilities, including transportation delays, expense fluctuations, and even political concerns. Shifting towards domestic procurement of Ivermectin offers a multitu